Johnson Investment Counsel Inc. Has $354.38 Million Stake in Procter & Gamble Company (The) $PG

Johnson Investment Counsel Inc. reduced its stake in Procter & Gamble Company (The) (NYSE:PG) by 0.5% in the third quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 2,306,381 shares of the company’s stock after selling 10,765 shares during the quarter. Procter & Gamble makes up 3.0% of Johnson Investment Counsel Inc.’s investment portfolio, making the stock its 5th largest holding. Johnson Investment Counsel Inc. owned 0.10% of Procter & Gamble worth $354,375,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors also recently modified their holdings of the company. Halbert Hargrove Global Advisors LLC bought a new stake in shares of Procter & Gamble in the third quarter valued at approximately $25,000. Corundum Trust Company INC purchased a new stake in Procter & Gamble in the third quarter valued at approximately $32,000. Mid American Wealth Advisory Group Inc. bought a new stake in shares of Procter & Gamble during the 2nd quarter worth $34,000. Marquette Asset Management LLC bought a new stake in Procter & Gamble in the 3rd quarter worth approximately $37,000. Finally, Manning & Napier Advisors LLC purchased a new position in shares of Procter & Gamble in the third quarter worth about $44,000. 65.77% of the stock is owned by institutional investors.

Procter & Gamble Stock Performance

Shares of PG opened at $157.28 on Tuesday. The company has a current ratio of 0.72, a quick ratio of 0.51 and a debt-to-equity ratio of 0.49. The firm has a market cap of $365.52 billion, a PE ratio of 23.30, a P/E/G ratio of 5.29 and a beta of 0.38. The stock has a fifty day moving average price of $145.95 and a 200-day moving average price of $150.29. Procter & Gamble Company has a 12 month low of $137.62 and a 12 month high of $179.99.

Procter & Gamble (NYSE:PG) last issued its earnings results on Thursday, January 22nd. The company reported $1.88 EPS for the quarter, beating analysts’ consensus estimates of $1.86 by $0.02. Procter & Gamble had a return on equity of 32.21% and a net margin of 19.30%.The firm had revenue of $22.21 billion for the quarter, compared to analyst estimates of $22.36 billion. During the same quarter in the prior year, the firm earned $1.88 earnings per share. Procter & Gamble’s revenue for the quarter was up 1.5% on a year-over-year basis. Procter & Gamble has set its FY 2026 guidance at 6.830-7.090 EPS. Equities research analysts predict that Procter & Gamble Company will post 6.91 earnings per share for the current fiscal year.

Procter & Gamble Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Tuesday, February 17th. Stockholders of record on Friday, January 23rd will be issued a dividend of $1.0568 per share. This represents a $4.23 annualized dividend and a dividend yield of 2.7%. The ex-dividend date is Friday, January 23rd. Procter & Gamble’s payout ratio is currently 62.67%.

Insider Buying and Selling at Procter & Gamble

In other news, insider Marc S. Pritchard sold 95,903 shares of the stock in a transaction on Friday, January 23rd. The stock was sold at an average price of $151.15, for a total transaction of $14,495,738.45. Following the completion of the transaction, the insider directly owned 182,607 shares in the company, valued at approximately $27,601,048.05. This represents a 34.43% decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, CEO Ma. Fatima Francisco sold 8,000 shares of the business’s stock in a transaction on Wednesday, February 4th. The stock was sold at an average price of $158.00, for a total value of $1,264,000.00. Following the transaction, the chief executive officer directly owned 6,571 shares of the company’s stock, valued at $1,038,218. The trade was a 54.90% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. 0.20% of the stock is owned by insiders.

Analyst Ratings Changes

Several equities analysts recently issued reports on the stock. Barclays set a $155.00 price target on shares of Procter & Gamble in a research report on Friday, January 16th. Piper Sandler assumed coverage on shares of Procter & Gamble in a report on Wednesday, January 7th. They set a “neutral” rating and a $150.00 price target on the stock. TD Cowen cut Procter & Gamble from a “buy” rating to a “hold” rating and upped their price objective for the company from $150.00 to $156.00 in a research report on Tuesday, January 27th. Raymond James Financial reduced their price target on Procter & Gamble from $185.00 to $175.00 and set an “outperform” rating for the company in a research report on Monday, October 20th. Finally, Rothschild & Co Redburn boosted their price target on Procter & Gamble from $155.00 to $157.00 and gave the stock a “neutral” rating in a report on Friday, January 23rd. Thirteen investment analysts have rated the stock with a Buy rating and eight have issued a Hold rating to the stock. According to data from MarketBeat, the company has an average rating of “Moderate Buy” and an average target price of $167.67.

Procter & Gamble Company Profile

Procter & Gamble (NYSE: PG) is a multinational consumer goods company headquartered in Cincinnati, Ohio. Founded in 1837 by William Procter and James Gamble, P&G has grown into one of the world’s largest producers of branded consumer packaged goods. The company focuses on developing, manufacturing and marketing a broad portfolio of household and personal care products sold to consumers and retailers worldwide.

P&G’s product offering spans several core business categories, including Beauty, Grooming, Health Care, Fabric & Home Care, and Baby, Feminine & Family Care.